Evidence map›Paper›PMID 31731729›Full record

ArticleJournal of clinical medicine2019

Interleukin-18 Is a Prognostic Biomarker Correlated with CD8

Minchan Gil, Kyung Eun Kim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Micronutrient Status and Breast Cancer: A Narrative Review.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Systematic Multiomic Analysis ofInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. The Role of IL-18 in P2RX7-Mediated Antitumor Immunity.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Minchan GilDepartment of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul 05029, Korea.
Kyung Eun KimDepartment of Cosmetic Sciences, Sookmyung Women's University, Seoul 04310, Korea.ORCID 0000-0003-2201-1280
Konkuk University · KRSookmyung Women's University · KR

Funding

National Research Foundation of Korea 2017R1D1A1A02018653National Research Foundation of Korea 2017R1D1A1B03036390
6 · The paper itself

Abstract

Interleukin-18 (IL-18) is a cytokine that enhances innate and adaptive immune responses. Although there are conflicting reports about the roles of IL-18 in melanoma progression, the clinical relevance of IL-18 expression has not been comprehensively studied. In this study, we investigated IL-18 expression and its correlation with patient survival and immune cell infiltration in melanoma using cancer gene expression data publicly available through various databases.

Indexed as

immune infiltratesInterleukin-18melanomamultiomic analysispatient survival

Identifiers

PMID31731729
PMCPMC6912818
OpenAlexW2989360867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.